Dr. Craig E. Devoe, MD

Dr. Devoe practices at Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York.

Dr. Devoe's NPI, 1407927593, was assigned on November 13, 2006. Dr. Devoe graduated from Stony Brook University Health Sciences Center School of Medicine in 1994. Dr. Devoe holds New York license 201557.

Dr. Devoe's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center, at 450 Lakeville Rd, Lake Success, NY 11042. The practice phone is (516) 734-8281.

Dr. Devoe's primary practice is Schlanger, Gottlieb Partners Council Breast Imaging Center in Lake Success, New York. Dr. Devoe is also affiliated with Long Island Jewish Medical Center. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Devoe to 2 more hospitals, 2 group practices and clinics, 1 clinical lab, 1 home health agency and 1 medical group, each named with a free account. Dr. Devoe's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devoe practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Devoe's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Devoe is licensed in New York.

CMS data shows 1,655 Medicare services from Dr. Devoe across 9 procedure codes in 2024, for 276 Medicare patients. Medicare paid $114,838 for them.

CMS counts 276 Medicare patients who saw Dr. Devoe in 2024. The largest group is 75 to 84, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devoe's median patient age at 73, with 44% women.

In 2024, Dr. Devoe wrote 453 Medicare Part D claims for 121 patients. 72% of them were for generic drugs. CMS names the drug for 268 of them, across 14 drugs with 11 or more claims each, at $584,967 in total drug cost. In 2023, CMS named 144 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Devoe for performance year 2024, reported as part of a group. Dr. Devoe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devoe as offering telehealth.

Dmand AI links 27 papers to Dr. Devoe, published from 2012 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Acute Kidney Injury and Carcinoma, Pancreatic Ductal. Dr. Devoe has published most often in Clin Cancer Res. Dr. Devoe's most frequent co-authors are Kenar Dinesh Jhaveri, MD, Richard D. Carvajal, MD and Steven L. Allen, MD.

Dmand AI links Dr. Devoe to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Neoplasm, Residual and Bile Duct Neoplasms.

CMS Open Payments shows 6 general payments to Dr. Devoe from 5 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 93% of the total. Pfizer Inc. paid the most, $3,150.

Dr. Devoe graduated from Stony Brook University Health Sciences Center School of Medicine in 1994.